Genor Biopharma Holdings Limited (06998.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.3x

Market Cap

HKD 2.83B

MomentumView details →

1D Return

+2.42%

YTD Return

−43.67%

RSI (14)

52.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

1.3x

Market Cap

HKD 2.83B

RSI (14)

52.9

MomentumView details →

1D Return

+2.42%

YTD Return

−43.67%

ProfitabilityView details →

Gross Margin

64.73%

Net Margin

14.81%

EBITDA Margin

31.65%

ROE (TTM)

23.61%

ROA (TTM)

15.43%

Asset Turnover

1.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+115.68%

FCF YoY

+152.51%

Revenue CAGR 3Y

+426.09%

EPS CAGR 3Y

−71.95%

EBITDA YoY

+278.33%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

−HKD 0.56

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.30x

Current Ratio

1.00x

Quick Ratio

0.78x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

6.34B

Net Income (TTM)

939.60M

Op. CF (TTM)

—

Next earningsMar 31, 2027 →

Latest newsMore news →

No recent news for 06998.HK.

Similar companies

Viva Biotech Holdings01873.HK SELLAS Life Sciences Group, Inc.SLS Soleno Therapeutics, Inc.SLNO BioDlink International Company Limited01875.HK 寿仙谷603896.SH Medtide Inc.03880.HK Find similar companies →

Latest newsMore news →

No recent news for 06998.HK.